Adverse Childhood Experiences Linked to Headache in Adulthood
FRIDAY, Oct. 27, 2023 -- Adverse childhood experiences (ACEs) are associated with primary headache in adulthood, according to a review published online Oct. 25 in Neurology.
Claudia Sikorski, Ph.D., from McMaster University in Hamilton, Ontario,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 27, 2023 Category: Pharmaceuticals Source Type: news
New migraine treatments could help ease misery for millions of Britons
Up to 20 percent of adults are thought to suffer from migraines, which can be painful and debilitating. (Source: Daily Express - Health)
Source: Daily Express - Health - October 27, 2023 Category: Consumer Health News Source Type: news
Opioids May Be Overused in Acute Treatment of Migraine Opioids May Be Overused in Acute Treatment of Migraine
A retrospective observational study of three migraine cohorts in Canada suggests that acute medications, particularly opioids, are overused and that preventive medications are underused.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 26, 2023 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Childhood Trauma Raises Odds for Adult Headaches
THURSDAY, Oct. 26, 2023 -- Children who live through trauma may be prone to having headaches as an adult.
New research found an association between headache disorders and traumatic events in childhood, such as abuse, neglect or household... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 26, 2023 Category: General Medicine Source Type: news
I've had an ongoing migraine for 9 MONTHS that feels like someone drilling into my head. Doctors aren't sure when it will end
Mitta Quissorcumar, from the UK, has struggled with migraines since her early 20s. But this January, one erupted which has been 'relentless' and refuses to go away. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2023 Category: Consumer Health News Source Type: news
Listening to SLIPKNOT could ease your headache... but scientists say there's a catch
Canadian scientists recruited 63 people who received moderately painful heat to their inner forearm - a sensation similar to a hot teacup being held against the skin. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2023 Category: Consumer Health News Source Type: news
Commonly Used Drug Amitriptyline Might Be New Treatment Option for IBS
WEDNESDAY, Oct. 18, 2023 -- An inexpensive medication long used for depression and migraines now has a clinical trial to back up its off-label use for another condition that lowers quality of life: irritable bowel syndrome (IBS).
In the study,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 18, 2023 Category: General Medicine Source Type: news
New Kids on the Block for Migraine Treatment and Prophylaxis New Kids on the Block for Migraine Treatment and Prophylaxis
Hans-Christoph Diener provides an update on acute migraine treatment and migraine prophylaxis, including new data from the 2023 International Headache Congress.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 17, 2023 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news
Beware risk of adverse events associated with GBCAs
Risks associated with gadolinium-based contrast agents (GBCAs) differ by drug, and clinicians would do well to educate themselves about these differences, according to research published October 14 in Expert Opinion on Drug Safety.To make the situation more complicated, not all possible adverse events from GBCAs are noted in drug packaging, wrote a team led by Lu Wang, PhD, of Yantai Yuhuangding Hospital in Yantai, China."Some adverse events [noted] in this study were not mentioned in the package inserts, which need more attention and research to ensure the clinical safety," the group explained.The U.S. Food and Drug Admin...
Source: AuntMinnie.com Headlines - October 17, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Clinical News MRI Source Type: news
Former CEO Pleads Guilty to Causing the Distribution of Adulterated and Misbranded Medical Devices Intended to Treat Migraine Headaches
FDA OCI, Mark Wright, Dolor Technologies, medical device, SphenoCath, migraine, headaches, nerve, block, no FDA clearance, approval, adulterated, misbranded, investigational, studies, sphenopalatine ganglion, SPG, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 16, 2023 Category: Medical Law Authors: DOJ Source Type: news
Does physiologic post-concussion disorder cause persistent post-traumatic headache? - McPherson JI, Nazir MSZ, Willer BS, Leddy JJ, Haider MN.
PURPOSE OF REVIEW: One system classifies patients with symptoms after concussion into physiologic, vestibulo-ocular, cervicogenic, and mood/cognition post-concussion disorders (PCD) based upon the preponderance of specific symptoms and physical impairments... (Source: SafetyLit)
Source: SafetyLit - October 16, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
What the location of your headache REALLY means
London-based GP Dr Ann Nainan says a forehead headache could be caused by eye strain, pain in the temple could be a cluster headache and a tension headache can cause pain at the back of the head. (Source: the Mail online | Health)
Source: the Mail online | Health - October 15, 2023 Category: Consumer Health News Source Type: news
6 Stories Show the Human Toll of Poland ’ s Strict Abortion Laws
This project was supported by the Pulitzer Center
[time-brightcove not-tgx=”true”]
Krzysztof Sowinski has cried every day since his wife Marta, who was five months pregnant, died of sepsis in 2022; he believes doctors put Marta’s life in danger by not giving them the option to terminate the pregnancy while the fetus’ heart was still beating. Janusz Kucharski also lost his partner Justyna to sepsis in the fifth month of a pregnancy. She left behind two boys.
It is likely, reproductive-rights advocates say, that these women would be alive if not for Poland’s increasingly restrictive abort...
Source: TIME: Health - October 13, 2023 Category: Consumer Health News Authors: Anna Pamula Tags: Uncategorized abortion Source Type: news
Late-breaking data for Roche ’s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis
New data from Phase II FENopta study in relapsing multiple sclerosis (RMS) show fenebrutinib crosses the blood-brain barrier with the potential to act directly on the chronic inflammation related to multiple sclerosis (MS)More than 90% relative reduction in new/enlarging T2 lesions and new T1 gadolinium-enhancing (Gd+) lesions with fenebrutinib beginning at 8 weeksThe safety profile of fenebrutinib was consistent with previous and ongoing clinical trials across more than 2,500 people to dateBasel, 13 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data from the Phase II FENopta study showing that inve...
Source: Roche Media News - October 13, 2023 Category: Pharmaceuticals Source Type: news
Late-breaking data for Roche ’s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis
New data from Phase II FENopta study in relapsing multiple sclerosis (RMS) show fenebrutinib crosses the blood-brain barrier with the potential to act directly on the chronic inflammation related to multiple sclerosis (MS)More than 90% relative reduction in new/enlarging T2 lesions and new T1 gadolinium-enhancing (Gd+) lesions with fenebrutinib beginning at 8 weeksThe safety profile of fenebrutinib was consistent with previous and ongoing clinical trials across more than 2,500 people to dateBasel, 13 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data from the Phase II FENopta study showing that inve...
Source: Roche Investor Update - October 13, 2023 Category: Pharmaceuticals Source Type: news
